Name: Latest research reports of Lupin Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 1
Author: ICICI Securities Limited

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

2188.4000 16.90 (0.78%)

NSE Aug 31, 2026 15:31 PM

Volume: 1.0M

Lupin Ltd.

09 Aug 2026

2188.40

0.78%

Headwinds in the US to impact growth

Sell: Lupin Ltd.

Recommendation

ICICI Securities Limited

Lupin delivered a strong Q1FY27, led by exclusivities in the US (+29.8%) and robust growth in emerging (+51.7%) and other developed markets (+48.3%).

Lupin Ltd. is trading below all available SMAs